Edition:
United States

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

0.44USD
1:24pm EST
Change (% chg)

$0.01 (+3.36%)
Prev Close
$0.43
Open
$0.44
Day's High
$0.44
Day's Low
$0.43
Volume
657
Avg. Vol
34,428
52-wk High
$1.56
52-wk Low
$0.32

Select another date:

Thu, Feb 1 2018

BRIEF-Dental Corporation Signs Letter Of Intent To Buy 3 Dental Clinics ‍​

* SIGNED LETTER OF INTENT TO BUY 3 DENTAL CLINICS WITH PRICE OF ABOUT 25 MILLION BAHT - 35 MILLION BAHT ‍​ Source text for Eikon: Further company coverage:

BRIEF-Biolase Releases Statement‍ In Response To Cao Group Litigation​

* RELEASED STATEMENT‍ IN RESPONSE TO CAO GROUP LITIGATION​ Source text for Eikon: Further company coverage:

BRIEF-CAO Group Filed Patent Infringement Lawsuits In Court Against Biolase

* CAO GROUP INC- FILED PATENT INFRINGEMENT LAWSUITS IN UNITED STATES DISTRICT COURT AGAINST BIOLASE INC Source text for Eikon: Further company coverage:

BRIEF-Biolase Files For Possible Resale Of Up To 21.9 Mln Shares Of Common Stock By Selling Stockholders

* BIOLASE INC FILES FOR POSSIBLE RESALE OF UP TO 21.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text - http://bit.ly/2Dj77iX Further company coverage:

BRIEF-Dental Corporation posts qtrly ‍net profit of 12.4 mln baht

* Qtrly ‍ net profit 12.4 million baht versus 12.2 million baht Source text for Eikon: Further company coverage:

BRIEF-Biolase announces commencement of rights offering

* Biolase announces commencement of rights offering Source text for Eikon: Further company coverage:

BRIEF-Biolase reports Q3 non-GAAP loss per share $0.05

* Q3 revenue rose 18 percent to $10.8 million Source text for Eikon: Further company coverage:

BRIEF-Biolase appoints Richard Lanman to board of directors

* Biolase - ‍Lanman replaces outgoing director Fredrick Moll​ Source text for Eikon: Further company coverage:

BRIEF-Biolase announces record date for previously announced proposed rights offering

* Biolase announces record date for previously announced proposed rights offering

BRIEF-Biolase names John Beaver as Chief Financial Officer

* Biolase names John Beaver Senior Vice President, Chief Financial Officer Source text for Eikon: Further company coverage:

Select another date: